Prof. Dr. med. Ulrike Mütze attended medical schools in Leipzig (Germany), Nice (France) and Berlin (Germany); followed by a doctorate (MD) at the University of Leipzig, Germany.

She is pediatrician by training and specialized in pediatric metabolic medicine, nutritional medicine, pediatric laboratory medicine, and newborn screening at the University Hospitals in Leipzig and Heidelberg (Germany).

As associate professor and consultant she works in clinical care for pediatric patients with inherited metabolic diseases and in the metabolic and newborn screening laboratory of the Division of Child Neurology and Metabolic Medicine, Department Pediatrics I, at Heidelberg University Hospital, Germany.

Her major research topic is the systematic evaluation of long-term outcome and lifelong care of individuals with inherited metabolic diseases identified by newborn screening. At Heidelberg University Hospital she and colleagues conducted the long-term observational study (NGS 2025) and evolved it to the world largest cohort of screened children, adolescents and young adults with inherited metabolic diseases. Dr Mütze and her group could prove the overall high long-term benefit of newborn screening on metabolic diseases for the identified individuals. Following the goal to reduce harm and enlarge benefit for screened individuals, they also identified needs for improvement of newborn screening programs, especially maintenance of a high process quality, clear case definitions, guideline development for diagnostics and treatment, and the evaluation of health benefits for possible new screening conditions.

For this work she received several research awards, especially the ISNS Jean Dussault Medal 2021, the Hufeland Award for preventive medicine in 2021 and the ESPED Investigator Award in 2024.